secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apogee Therapeutics, Inc. (APGE)
CIK:        0001974640
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0001104659-24-065322
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apogee Therapeutics appoints Lisa Bollinger, MD to board of directors
---------------------------------------------------------------------

- Lisa Bollinger, MD elected as Class II director, effective May 28, 2024.
- Bollinger brings 30+ years in drug development; most recently VP Regulatory Affairs at Merck (MRK).
- She also served as VP Global Patient Safety at Amgen and 12 years at FDA.
- Will serve on the Nominating and Corporate Governance Committee.
- Appointment adds regulatory and safety expertise as Apogee advances two clinical programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1974640/000110465924065322/0001104659-24-065322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1974640/000110465924065322/tm2415611d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-065322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer